Nav: Home

Study examines FDA drug, device approvals based on nonrandomized clinical trials

September 11, 2019

Bottom Line: How often the U.S. Food and Drug Administration (FDA) has approved drugs and devices based on nonrandomized clinical trials (non-RCTs) and whether those approvals are associated with the sizes of treatment effects were the focus of this study. Applications for 606 drugs from 2012 to August 2018 and for 71 medical devices from 1996 to August 2017 were assessed, and approved applications based on non-RCTs were included in this study called a systematic review and meta-analysis. Of the 677 applications, 68 (10%) were approved by the FDA based on non-RCTs. A meta-analysis was conducted to examine differences between applications that required further testing with RCTs and those that didn't. The authors report estimated treatment effects were higher for treatments or devices approved based on non-RCTs than for treatments or devices for which further testing in RCTs was required. There was no clear threshold of treatment effect above which no RCTs were requested. A limitation of the study was the small sample size.

Authors: Benjamin Djulbegovic, M.D., Ph.D., City of Hope, Duarte, California, and coauthors

(doi:10.1001/jamanetworkopen.2019.11111)

Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
-end-
Media advisory: To contact corresponding author Benjamin Djulbegovic, M.D., Ph.D., email Letisia Marquez at lemarquez@coh.org">lemarquez@coh.org. The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time: http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2019.11111?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=091119

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. Every Wednesday and Friday, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

JAMA Network Open

Related Medical Devices Articles:

Researchers make flexible glass for tiny medical devices
Brigham Young University researchers have developed new glass technology that could add a new level of flexibility to the microscopic world of medical devices.
High-risk medical devices: IQWiG sees no potential in 6 of 8 cases
Only case series without informative value are available for most indications.
New low-cost method to produce light-based lab-on-a-chip devices for fast medical tests
A new fabrication process could make it easier and less expensive to incorporate optical sensing onto lab-on-a-chip devices.
Study points a way to better implantable medical devices
MIT researchers have identified a signaling molecule key to the formation of scar tissue surrounding implantable medical devices, a process called fibrosis.
Anti-bacterial discovery will prevent infections spreading on medical devices
Bacterial biofilms frequently attach to medical devices in the body, such as hip replacements and heart valves, after surgery.
More Medical Devices News and Medical Devices Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...